Trial Profile
A 3-Month, Open, Randomised Trial Comparing the Efficacy and Safety of the Association Valproate-Amisulpride to the Association Valproate-Haloperidol in Bipolar I Patients Suffering From a Manic Episode.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Amisulpride (Primary) ; Haloperidol; Valproic acid
- Indications Bipolar I disorders
- Focus Therapeutic Use
- Acronyms SOLMANIA
- Sponsors Sanofi
- 07 Jul 2009 Additional lead trial investigator added as reported by ClinicalTrials.gov
- 21 Jan 2006 New trial record.